Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study checks blood thinner safety in korean heart patients

NCT ID NCT06874894

First seen Jan 11, 2026 · Last updated Jun 11, 2026 · Updated 18 times

Summary

This study looks at how safe and effective newer blood thinners (NOACs) are for Korean adults with atrial fibrillation, a heart rhythm problem that raises stroke risk. Researchers will track about 1,000 patients for strokes, bleeding, and heart events. The goal is to better understand the benefits and risks in this specific population.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FIBRILLATION, ATRIAL are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Chung-Ang University Gwangmyeong Hospital

    Gwangmyeong, South Korea

  • Chung-Ang University Hospital

    Seoul, 06973, South Korea

Conditions

The condition(s) this trial relates to.

atrial fibrillation Hemorrhage stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.